Delivery Order SPE2DB24D2010-SPE2DB25FZZX0

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $13,538.09, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract provides for the delivery of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with an ultimate completion date of June 24, 2025. The contract is a firm fixed-price arrangement without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of PROLIA 60 MG/ML SYRINGE. The contract has a ceiling value of $10,714.50 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.90 firm fixed-price delivery order is for the supply of PROLIA 60 MG/ML SYRINGE medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $18,297.65, is for the supply of PROLIA 60 MG/ML syringes. The contract has a period of performance through September 12, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of PROLIA 60 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,887.54 and runs through April 25, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,965.32, is a Firm Fixed Price Delivery Order for the supply of PROLIA 60 MG/ML SYRINGEML. The contract has an ultimate completion date of April 2, 2025 and was awarded on April 1, 2025. The contract is not designated with a set-aside. In addition to this specific award, Amerisourcebergen holds a...
This federal contract award is for $14,214.62 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of May 22, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,264.23, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with a ceiling value of $31,265.59 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PROLIA 60 MG/ML syringes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,142.90 and an ultimate completion date of March 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZZX0
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROLIA 60 MG/ML SYRINGE medication, with a ceiling value of $12,278.32 and a period of performance through June 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA, U.S. Coast Guard, and Defense Health Agency. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely a specific delivery order under that larger IDC contract, enabling Amerisourcebergen to supply a range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 9/16/25, 10:00 AM